JP2018510962A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018510962A5 JP2018510962A5 JP2018503836A JP2018503836A JP2018510962A5 JP 2018510962 A5 JP2018510962 A5 JP 2018510962A5 JP 2018503836 A JP2018503836 A JP 2018503836A JP 2018503836 A JP2018503836 A JP 2018503836A JP 2018510962 A5 JP2018510962 A5 JP 2018510962A5
- Authority
- JP
- Japan
- Prior art keywords
- mixture
- eye
- bixin
- carbonyldiimidazole
- dmf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 description 5
- RAFGELQLHMBRHD-VFYVRILKSA-N Bixin Natural products COC(=O)C=CC(=C/C=C/C(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)/C)C RAFGELQLHMBRHD-VFYVRILKSA-N 0.000 description 2
- RAFGELQLHMBRHD-UHFFFAOYSA-N alpha-Fuc-(1-2)-beta-Gal-(1-3)-(beta-GlcNAc-(1-6))-GalNAc-ol Natural products COC(=O)C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC(O)=O RAFGELQLHMBRHD-UHFFFAOYSA-N 0.000 description 2
- 239000001670 anatto Substances 0.000 description 2
- 235000012665 annatto Nutrition 0.000 description 2
- RAFGELQLHMBRHD-SLEZCNMESA-N bixin Chemical compound COC(=O)\C=C\C(\C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C(O)=O RAFGELQLHMBRHD-SLEZCNMESA-N 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- -1 hyaluronic acid retinoic acid ester Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- 210000003014 totipotent stem cell Anatomy 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITFI2015A000102 | 2015-04-07 | ||
| ITFI20150102 | 2015-04-07 | ||
| PCT/IB2016/051960 WO2016162809A1 (en) | 2015-04-07 | 2016-04-07 | Glycosaminoglycan esters, processes for their preparation and their use in formulations for ophthalmic use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018510962A JP2018510962A (ja) | 2018-04-19 |
| JP2018510962A5 true JP2018510962A5 (cg-RX-API-DMAC10.html) | 2019-05-16 |
| JP6847091B2 JP6847091B2 (ja) | 2021-03-24 |
Family
ID=53719816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018503836A Expired - Fee Related JP6847091B2 (ja) | 2015-04-07 | 2016-04-07 | グリコサミノグリカンエステル、それらを調製する方法および眼科用途のための製剤におけるそれらの使用 |
Country Status (12)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202000012535A1 (it) * | 2020-05-27 | 2021-11-27 | Stefano Colombo | Composizione oftalmica a base di acido ialuronico per la protezione dai danni causati dall’inquinamento ambientale |
| WO2022094695A1 (en) | 2020-11-03 | 2022-05-12 | Institut National De La Recherche Scientifique | A method and a system for compressed ultrafast tomographic imaging |
| CN116284495B (zh) * | 2023-03-20 | 2024-08-30 | 润辉生物技术(威海)有限公司 | 全反式维甲酸低分子透明质酸酯衍生物及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4851521A (en) * | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
| IT1281877B1 (it) * | 1995-05-10 | 1998-03-03 | Fidia Advanced Biopolymers Srl | Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici |
| ITTS20010017A1 (it) * | 2001-07-17 | 2003-01-17 | Ct Ricerche Polytech Soc Coop | Esteri polisaccaridici di acido retinoico. |
| ITMI20022745A1 (it) * | 2002-12-23 | 2004-06-24 | Coimex Scrl United Companies | Esteri misti dell'acido ialuronico ad attivita' citostatica e prodifferenziante e procedimento per la loro produzione. |
| ITMI20030043A1 (it) * | 2003-01-14 | 2004-07-15 | Coimex S C R L United Companies | Uso di esteri retinoici dell'acido ialuronico in cellule |
| WO2005077176A1 (en) * | 2004-02-11 | 2005-08-25 | The Trustees Of Columbia University In The City Of New York | Anthocyanin compounds and methods of use thereof |
| ITMI20040347A1 (it) * | 2004-02-26 | 2004-05-26 | Pharma Medical Ltd | Nuovo farmaco di associazione |
| US20070207116A1 (en) * | 2006-03-01 | 2007-09-06 | Brown David C | Antioxidant compositions for the eye |
| ITMI20062134A1 (it) * | 2006-11-08 | 2008-05-09 | Cbb Net S A | Preparaziobne di esteri della diacereina con acido ialuronico e loro formulazioni per l'impiego farmaceutico |
| US8865685B2 (en) * | 2011-06-30 | 2014-10-21 | Johnson & Johnson Vision Care, Inc. | Esters for treatment of ocular inflammatory conditions |
| CA2886115A1 (en) * | 2012-10-02 | 2014-04-10 | Allergan, Inc. | Dermal filler hydrogels with vitamin a/cyclodextrin inclusion complexes |
-
2016
- 2016-04-06 MA MA041912A patent/MA41912A/fr unknown
- 2016-04-07 WO PCT/IB2016/051960 patent/WO2016162809A1/en not_active Ceased
- 2016-04-07 JP JP2018503836A patent/JP6847091B2/ja not_active Expired - Fee Related
- 2016-04-07 RU RU2017138283A patent/RU2726192C2/ru active
- 2016-04-07 AU AU2016244391A patent/AU2016244391B2/en not_active Ceased
- 2016-04-07 BR BR112017021608A patent/BR112017021608A2/pt not_active IP Right Cessation
- 2016-04-07 CN CN201680025075.2A patent/CN107636020A/zh active Pending
- 2016-04-07 KR KR1020177032142A patent/KR20180002674A/ko not_active Ceased
- 2016-04-07 CA CA2981861A patent/CA2981861A1/en not_active Abandoned
- 2016-04-07 ES ES16726940T patent/ES2888648T3/es active Active
- 2016-04-07 EP EP16726940.6A patent/EP3280396B1/en active Active
- 2016-04-07 US US15/564,994 patent/US10328097B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201890618A1 (ru) | Способы и композиции для лечения состояний, ассоциированных с аномальными воспалительными ответами | |
| WO2011159550A3 (en) | Lysophosphatidic acid receptor antagonist and uses thereof | |
| EA201390840A1 (ru) | Полициклический lpaантагонист и его применение | |
| WO2013066839A3 (en) | Compounds and methods | |
| IN2012DE00337A (cg-RX-API-DMAC10.html) | ||
| MD4673B1 (ro) | Letermovir amorf şi forme preparative farmaceutice solide ale acestuia pentru administrare orală | |
| JP2017535521A5 (cg-RX-API-DMAC10.html) | ||
| EA202090259A1 (ru) | Новые гетероариламидные производные как селективные ингибиторы гистондеацетилаз 1 и/или 2 (hdac1-2) | |
| JP2015078201A5 (cg-RX-API-DMAC10.html) | ||
| WO2015104292A3 (en) | Compounds for use in treating or preventing cancerous diseases | |
| MX388300B (es) | Proceso para la preparación de derivados de ácidos biliares de sulfonil carbamato | |
| JP2015511957A5 (cg-RX-API-DMAC10.html) | ||
| EA202090500A1 (ru) | Кристаллические формы иммуномодуляторов | |
| RU2019119405A (ru) | Лиофилизированные фармацевтические композиции далбаванцина | |
| HK1203394A1 (en) | Ghrelin receptor agonists for the treatment of achlorhydria | |
| HRP20220544T1 (hr) | Nove soli i polimorfi scy-078 | |
| ES2791295T3 (es) | Procedimiento para purificar ácido ferúlico y/o sales del mismo | |
| CL2020001420A1 (es) | Procedimiento para la preparación de (3s)-3-(4-cloro-3-{[(2s,3r)-2-(4-clorofenil)-4,4,4-trifluor-3-metilbutanoil] amino}fenil)-3-ácido ciclopropilpropanoico y su forma cristalina para uso como principio activo farmacéutico. | |
| PH12012501349A1 (en) | Dp2 antagonist and uses thereof | |
| AR081267A1 (es) | Procedimiento de obtencion de la forma cristalina a del febuxostat | |
| HRP20220234T1 (hr) | Kristalni oblici | |
| TW201513854A (zh) | 用於馬的炎症治療之製劑 | |
| AR079299A1 (es) | Mejora de los procesos para la preparacion de granulos solubles de las sales de los acidos carboxilicos que contienen piridina | |
| CN103550755B (zh) | 一种氟苯尼考硫酸粘菌素可溶性粉及其制备方法 | |
| JP2017008001A5 (cg-RX-API-DMAC10.html) |